Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.34 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4361438 | 0.92 | MAPT (0.37) | LMNADRD2DRD3HTR1A | |
| SCHEMBL11897301 | 0.92 | MAPT (0.37) | LMNADRD2DRD3HTR1A | |
| SCHEMBL31374750 | 0.88 | DRD2 (0.45) | LMNADRD2DRD3HTR1A | |
| SCHEMBL26132063 | 0.88 | DRD2 (0.42) | LMNADRD2DRD3HTR1ASLC2A1 | |
| SCHEMBL302762 | 0.86 | CSNK2A2 (0.43) | RAB9ADRD3 | |
| SCHEMBL10598698 | 0.86 | KCNH2 (0.40) | LMNAHTR1A | |
| SCHEMBL11897011 | 0.83 | LMNA (0.33) | LMNADRD2DRD3 | |
| SCHEMBL329772 | 0.83 | HRH3 (0.46) | LMNAMEN1KMT2AHTR1A | |
| SCHEMBL14814163 | 0.82 | MAPK1 (0.37) | MAPK1RAB9AKDM1AMEN1KMT2A | |
| SCHEMBL9420805 | 0.82 | ALOX15 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055216-A1 | Conjugated Diene-Based Polymer, Formed Body, Production Method for Conjugated Diene-Based Polymer, Rubber Composition, and Tire | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-02-26 | — | — | US | disclosed |
| CN-119497723-A | Conjugated diene polymer, molded article, method for producing conjugated diene polymer, rubber composition, and tire | 旭化成株式会社 | 2025-02-21 | — | — | CN | disclosed |
| EP-2615134-B1 | RUBBER COMPOSITION AND PROCESS FOR PRODUCTION THEREOF, AND TIRE | JSR CORP (JP) | 2018-07-18 | — | — | EP | disclosed |
| EP-2987808-A2 | MODIFIED CONJUGATED DIENE RUBBER, METHOD FOR PRODUCING SAME, AND RUBBER COMPOSITION | JSR Corporation (JP) | 2016-02-24 | — | — | EP | disclosed |
| US-9212276-B2 | Modified conjugated diene rubber, method for producing same, and rubber composition | JSR CORPORATION (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9145485-B2 | Rubber composition and process for production thereof, and tire | JSR CORPORATION (JP) | 2015-09-29 | — | — | US | disclosed |
| EP-2581391-B1 | MODIFIED CONJUGATED DIENE RUBBER, METHOD FOR PRODUCING SAME, AND RUBBER COMPOSITION | JSR CORP (JP) | 2015-08-19 | — | — | EP | disclosed |
| US-8946349-B2 | — | — | 2015-02-03 | — | — | US | disclosed |
| EP-2615134-A1 | RUBBER COMPOSITION AND PROCESS FOR PRODUCTION THEREOF, AND TIRE | JSR Corporation (JP) | 2013-07-17 | — | — | EP | disclosed |
| US-20130172481-A1 | RUBBER COMPOSITION AND PROCESS FOR PRODUCTION THEREOF, AND TIRE | JSR CORPORATION (JP) | 2013-07-04 | — | — | US | disclosed |
| EP-2581391-A1 | MODIFIED CONJUGATED DIENE RUBBER, METHOD FOR PRODUCING SAME, AND RUBBER COMPOSITION | JSR Corporation (JP) | 2013-04-17 | — | — | EP | disclosed |
| US-20130085228-A1 | MODIFIED CONJUGATED DIENE RUBBER, METHOD FOR PRODUCING SAME, AND RUBBER COMPOSITION | JSR CORPORATION (JP) | 2013-04-04 | — | — | US | disclosed |
| US-20080176227-A1 | Dna Carrier, Method of Producing the Same and Collection System Using the Same | CANON KABUSHIKI KAISHA (JP) | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055216-A1 | Conjugated Diene-Based Polymer, Formed Body, Production Method for Conjugated Diene-Based Polymer, Rubber Composition, and Tire | HMGB2, HMGB1, HMGB3 | MAPK1 2469/4885RAB9A 3559/4885LMNA 1042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.